JP4726269B2 - Oral solution - Google Patents
Oral solution Download PDFInfo
- Publication number
- JP4726269B2 JP4726269B2 JP30260196A JP30260196A JP4726269B2 JP 4726269 B2 JP4726269 B2 JP 4726269B2 JP 30260196 A JP30260196 A JP 30260196A JP 30260196 A JP30260196 A JP 30260196A JP 4726269 B2 JP4726269 B2 JP 4726269B2
- Authority
- JP
- Japan
- Prior art keywords
- vitamin
- food
- oral solution
- internal
- tonic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Description
【0001】
【産業上の利用分野】
本発明は、ビタミンCを含有する内服液剤または食品飲料に関する。
【0002】
【従来の技術及び発明が解決しようとする課題】
ビタミンCはグァバ、イチゴ、レモンのような果実などから摂取できる。あるいはビタミンCを配合した滋養強壮用内服液剤や食品飲料などからも摂取できる。
滋養強壮用液剤や食品飲料には通常、アミノ酸やビタミン、無機塩類などを配合するが、これらは苦味や不快な味を呈するものが少なくない。このため、滋養強壮用液剤や食品飲料には、呈味に代表される服用感を好ましいものとするために甘味料や香料が常用されている。
このため、果実や滋養強壮用内服液剤、食品飲料には通常果糖や砂糖などの糖類がかなりの量配合されており、これらから充分量のビタミンCを摂取するためにはかなりの糖類を摂取してしまう結果、カロリー過剰になり、成人病予防などの観点から問題があった。
【0003】
また、滋養強壮用内服液剤や食品飲料は、口当りの改善や清涼感を与えるためにpHを2〜4.5程度に設定するのが通常である。
ところが、上記条件において滋養強壮用内服液剤や食品飲料にビタミンCを配合すると、速やかにビタミンCが分解してしまいビタミンCとしての生理活性を有しない分解物に変換してしまう。
また、滋養強壮用内服液剤や食品飲料にビタミンCとビタミンB類(特にビタミンB1 、その塩及びそれらの誘導体)が同時に配合されている場合には、経時的に独特な不快臭が強くなり、服用感の著しい低下をきたしてしまう。
本発明の目的は、これらの問題を解決した滋養強壮用内服液剤または食品飲料を提供することにある。
【0004】
【課題を解決するための手段】
本発明者らは鋭意研究した結果、ビタミンCを配合したpH2〜4.5の滋養強壮用液剤または食品飲料において、甘味料としてステビア抽出物および糖アルコールを配合すると、問題を解決できることを見いだし、本発明を完成した。
すなわち、本発明は、ビタミンC、ステビア抽出物および糖アルコールを配合したpH2〜4.5の内服液剤または食品飲料である。
【0005】
本発明において、ビタミンCとは、L−アスコルビン酸、その塩、そのエステル及びその誘導体を指し、具体的にはアスコルビン酸ナトリウム、アスコルビン酸カリウム、アスコルビン酸モノステアレート、アスコルビン酸モノパルミテート、アスコルビン酸モノオレエートなどを挙げることができる。ビタミンCの配合量は0.01〜10重量%、好ましくは0.5〜6重量%である。
【0006】
また、ステビア抽出物としては公知の各種ステビア抽出物を使用できるが、具体的にはリバウデオサイドA、リバウデオサイドB、リバウデオサイドC、リバウデオサイドD、リバウデオサイドE、ステビオサイド、ダルコサイドA、ダルコサイドB、ステビオールなどであり、これらは2種以上を混合して用いることもできる。これらの中ではリバウデオサイドAまたはステビオサイドが最も好ましい。ステビア抽出物の配合量は、0.005〜0.1重量%である。製剤中にビタミンB1のような不快な風味を呈する成分を配合する場合には、その苦味の程度に応じて、苦味成分1.0重量%に対して2.0〜12.5重量%ずつ増量することができる。
【0007】
さらに、糖アルコールとしてはマルチトール、ソルビトール、キシリトール、エリスリトールなどを挙げることができ、これらの1種または2種以上を配合することができる。中でも好ましい糖アルコールはマルチトールまたはエリスリトールである。糖アルコールの配合量は、ステビア抽出物との配合比により決まり、ステビア抽出物の甘味度を1としたときに0.1〜10の甘味度になる量を配合する。
【0008】
本発明においては、前記必須成分にビタミンB類(特に不快な風味の強いビタミンB1、その塩およびそれらの誘導体)を配合した場合でも内服液剤または食品飲料の風味が良好であることが特徴である。
ビタミンB類とは、ビタミンB1、ビタミンB2、ビタミンB6、ビタミンB12、それらの塩、それらのエステル及びそれらの誘導体(例えば、ビスイブチアミン、ジセチアミン、フルスルチアミン、ベンフォチアミンなど)を指す。
【0009】
本発明の内服液剤または食品飲料には、上記成分の他、通常内服液剤または食品飲料に用いる成分、例えば他の各種ビタミン(例えばビタミンA、ビタミンD、ビタミンE、ビタミンPおよびそれらの塩、エステル、誘導体)、アミノ酸(例えばタウリン、L−アスパラギン酸、L−アルギニン、トリプトファン、リジン)、生薬(例えばムイラプアマ、ニンジン、ジオウ)、カフェイン、ローヤルゼリー、多価アルコール(例えばプロピレングリコール)、有機酸(例えばクエン酸、乳酸、コハク酸、リンゴ酸)、pH調整剤(例えばクエン酸ナトリウム)、カフェイン、香料、保存剤などを本発明の効果を損なわない範囲で配合することができる。
【0010】
【実施例】
以下、実施例、比較例および試験例を挙げて本発明をさらに詳細に説明する。
上記各成分を混合溶解することにより、内服液剤を得た。
【0011】
上記各成分を混合溶解することにより、内服液剤を得た。
【0012】
上記各成分を混合溶解することにより、内服液剤を得た。
【0013】
上記各成分を混合溶解することにより、内服液剤を得た。
【0014】
比較例1
実施例1において、マルチトール15000mgおよびステビア抽出物15mgのかわりに砂糖12gを用いた他は実施例1と同様にして内服液剤を得た。
【0015】
比較例2
実施例1において、マルチトール15000mgのかわりに果糖11gを用いた他は実施例1と同様にして内服液剤を得た。
【0016】
比較例3
実施例1において、クエン酸ナトリウムを用いてpHを3.5から5.3にした他は実施例1と同様にして内服液剤を得た。
【0017】
試験例1[官能試験]
実施例1および実施例2で得られた内服液剤および比較例1および2で得られた内服液剤について、11名のパネルにより、内服液剤としての官能試験を行った。各試料20mlを少量ずつ交互に服用し、服用後(2〜3分)の印象を相対的に評価した。官能試験項目として、ビタミンCのイメージ、低カロリー感、飲みやすさについて下記の5段階評価基準(表1)で評価し、平均点を算出した。
結果を表2に示す。
【0018】
【表1】
【0019】
【表2】
【0020】
試験例2[ビタミンCの安定性試験]
実施例1および実施例2で得られた内服液剤および比較例1〜3で得られた内服液剤を、65℃に保存してビタミンCの安定性について比較した。ビタミンCの定量は高速液体クロマトグラフ法により行った。結果を表3に示す。
【0021】
【表3】
[0001]
[Industrial application fields]
The present invention relates to an internal liquid or food drink containing vitamin C.
[0002]
[Prior art and problems to be solved by the invention]
Vitamin C can be taken from fruits such as guava, strawberries and lemons. Alternatively, it can be ingested from a nutritional tonic preparation or vitamin drink containing vitamin C.
Nutrition tonic liquids and food drinks usually contain amino acids, vitamins, inorganic salts, etc., but these often have a bitter or unpleasant taste. For this reason, sweeteners and fragrances are commonly used in nourishing tonic liquids and food drinks in order to make the feeling of taking typified by taste good.
For this reason, saccharides such as fructose and sugar are usually included in fruits, nutritional tonics, and food and beverages. In order to obtain a sufficient amount of vitamin C, a considerable amount of saccharide is ingested. As a result, calories were excessive, and there were problems from the viewpoint of preventing adult diseases.
[0003]
Moreover, it is normal to set pH to about 2-4.5 in order to give a mouthfeel improvement and a refreshing sensation for the oral solution for nutrition and tonic and food drink.
However, when vitamin C is added to a nutritional tonic internal use liquid or food drink under the above conditions, vitamin C is rapidly decomposed and converted into a decomposed product having no physiological activity as vitamin C.
In addition, when vitamin C and vitamin B (especially vitamin B 1 , its salts and their derivatives) are blended at the same time in a nourishing tonic liquid or food and beverage, a unique unpleasant odor becomes stronger over time. , The feeling of taking will be significantly reduced.
An object of the present invention is to provide an oral solution for nutrition and tonic or a food and beverage that solves these problems.
[0004]
[Means for Solving the Problems]
As a result of diligent research, the present inventors have found that, when a stevia extract and a sugar alcohol are blended as sweeteners in a tonic solution or food beverage having a pH of 2 to 4.5 blended with vitamin C, the problem can be solved. The present invention has been completed.
That is, the present invention is an internal solution or food drink having a pH of 2 to 4.5 and containing vitamin C, stevia extract and sugar alcohol.
[0005]
In the present invention, vitamin C refers to L-ascorbic acid, salts thereof, esters thereof and derivatives thereof. Specifically, sodium ascorbate, potassium ascorbate, ascorbic acid monostearate, ascorbic acid monopalmitate, ascorbine Examples include acid monooleate. The amount of vitamin C is 0.01 to 10% by weight, preferably 0.5 to 6% by weight.
[0006]
As the stevia extract, various known stevia extracts can be used, and specifically, rebaudioside A, rebaudioside B, rebaudioside C, rebaudioside D, rebaudioside E, stevioside, darcoside A, dalcoside B, steviol and the like, and these may be used in combination of two or more. Of these, rebaudioside A or stevioside is most preferred. The compounding quantity of a stevia extract is 0.005-0.1 weight%. When blending a component exhibiting an unpleasant flavor such as vitamin B 1 in the preparation, 2.0 to 12.5% by weight with respect to 1.0% by weight of the bitter component depending on the degree of bitterness. Can be increased.
[0007]
Furthermore, examples of the sugar alcohol include maltitol, sorbitol, xylitol, erythritol, and the like, and one or more of these can be blended. Among them, a preferred sugar alcohol is maltitol or erythritol. The compounding quantity of sugar alcohol is decided by the compounding ratio with a stevia extract, and when the sweetness degree of a stevia extract is set to 1, the quantity which becomes a sweetness degree of 0.1-10 is mix | blended.
[0008]
In the present invention, even when vitamin Bs (particularly unpleasant and strong vitamin B 1 , salts thereof and derivatives thereof) are blended with the essential components, the flavor of the oral solution or food drink is good. is there.
Vitamin B refers to vitamin B 1 , vitamin B 2 , vitamin B 6 , vitamin B 12 , salts thereof, esters thereof and derivatives thereof (for example, bisibutiamine, dicetiamine, fursultiamine, benfotiamine, etc. ).
[0009]
In addition to the above-mentioned components, the internal liquid or food drink of the present invention usually contains components used for internal liquids or food drinks, such as other various vitamins (for example, vitamin A, vitamin D, vitamin E, vitamin P and their salts, esters). , Derivatives), amino acids (eg taurine, L-aspartic acid, L-arginine, tryptophan, lysine), herbal medicines (eg muirapuama, carrot, diau), caffeine, royal jelly, polyhydric alcohols (eg propylene glycol), organic acids ( For example, citric acid, lactic acid, succinic acid, malic acid), a pH adjuster (for example, sodium citrate), caffeine, a fragrance, a preservative, and the like can be blended within a range that does not impair the effects of the present invention.
[0010]
【Example】
Hereinafter, the present invention will be described in more detail with reference to Examples, Comparative Examples, and Test Examples.
An internal solution was obtained by mixing and dissolving the above components.
[0011]
An internal solution was obtained by mixing and dissolving the above components.
[0012]
An internal solution was obtained by mixing and dissolving the above components.
[0013]
An internal solution was obtained by mixing and dissolving the above components.
[0014]
Comparative Example 1
In Example 1, an oral solution was obtained in the same manner as in Example 1 except that 12 g of sugar was used instead of 15,000 mg of maltitol and 15 mg of stevia extract.
[0015]
Comparative Example 2
In Example 1, an oral solution was obtained in the same manner as in Example 1 except that 11 g of fructose was used instead of 15000 mg of maltitol.
[0016]
Comparative Example 3
In Example 1, an internal solution was obtained in the same manner as in Example 1 except that sodium citrate was used to change the pH from 3.5 to 5.3.
[0017]
Test Example 1 [Sensory test]
About the internal use liquid agent obtained in Example 1 and Example 2 and the internal use liquid agent obtained in Comparative Examples 1 and 2, the sensory test as an internal use liquid agent was conducted by 11 panels. 20 ml of each sample was alternately taken in small amounts, and the impression after taking (2 to 3 minutes) was relatively evaluated. As sensory test items, the image of vitamin C, the feeling of low calories, and ease of drinking were evaluated according to the following five-level evaluation criteria (Table 1), and the average score was calculated.
The results are shown in Table 2.
[0018]
[Table 1]
[0019]
[Table 2]
[0020]
Test Example 2 [Vitamin C Stability Test]
The internal liquid preparations obtained in Example 1 and Example 2 and the internal liquid preparations obtained in Comparative Examples 1 to 3 were stored at 65 ° C. and compared for the stability of vitamin C. Vitamin C was quantified by high performance liquid chromatography. The results are shown in Table 3.
[0021]
[Table 3]
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30260196A JP4726269B2 (en) | 1995-11-16 | 1996-11-14 | Oral solution |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29818595 | 1995-11-16 | ||
JP7-298185 | 1995-11-16 | ||
JP1995298185 | 1995-11-16 | ||
JP30260196A JP4726269B2 (en) | 1995-11-16 | 1996-11-14 | Oral solution |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH09194370A JPH09194370A (en) | 1997-07-29 |
JP4726269B2 true JP4726269B2 (en) | 2011-07-20 |
Family
ID=26561406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP30260196A Expired - Lifetime JP4726269B2 (en) | 1995-11-16 | 1996-11-14 | Oral solution |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4726269B2 (en) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9811606D0 (en) * | 1998-05-30 | 1998-07-29 | Cerestar Holding Bv | Liquid products containing erythritol |
JP5182331B2 (en) * | 1999-04-06 | 2013-04-17 | 大正製薬株式会社 | Riboflavin formulation solution composition |
JP4678079B2 (en) * | 1999-04-06 | 2011-04-27 | 大正製薬株式会社 | Riboflavin formulation solution composition |
JP2002060339A (en) * | 2000-08-17 | 2002-02-26 | Takeda Chem Ind Ltd | High sweetness degree sweetner-containing composition and its utilization |
DK1526779T3 (en) * | 2002-07-25 | 2008-01-28 | Ricola Ag | Confectionery based on herbs |
US8956677B2 (en) | 2005-11-23 | 2015-02-17 | The Coca-Cola Company | High-potency sweetener composition with glucosamine and compositions sweetened therewith |
US9144251B2 (en) | 2005-11-23 | 2015-09-29 | The Coca-Cola Company | High-potency sweetener composition with mineral and compositions sweetened therewith |
US8524303B2 (en) * | 2005-11-23 | 2013-09-03 | The Coca-Cola Company | High-potency sweetener composition with phytosterol and compositions sweetened therewith |
US8940350B2 (en) | 2005-11-23 | 2015-01-27 | The Coca-Cola Company | Cereal compositions comprising high-potency sweeteners |
US8940351B2 (en) | 2005-11-23 | 2015-01-27 | The Coca-Cola Company | Baked goods comprising high-potency sweetener |
DK2526783T3 (en) * | 2005-11-23 | 2017-02-06 | Coca Cola Co | Natural high-potency sweetener compositions with improved time profile and / or flavor profile |
US8512789B2 (en) | 2005-11-23 | 2013-08-20 | The Coca-Cola Company | High-potency sweetener composition with dietary fiber and compositions sweetened therewith |
US20070116829A1 (en) * | 2005-11-23 | 2007-05-24 | The Coca-Cola Company | Pharmaceutical Composition with High-Potency Sweetener |
US8956678B2 (en) | 2005-11-23 | 2015-02-17 | The Coca-Cola Company | High-potency sweetener composition with preservative and compositions sweetened therewith |
US8993027B2 (en) * | 2005-11-23 | 2015-03-31 | The Coca-Cola Company | Natural high-potency tabletop sweetener compositions with improved temporal and/or flavor profile, methods for their formulation, and uses |
US8377491B2 (en) * | 2005-11-23 | 2013-02-19 | The Coca-Cola Company | High-potency sweetener composition with vitamin and compositions sweetened therewith |
US8945652B2 (en) | 2005-11-23 | 2015-02-03 | The Coca-Cola Company | High-potency sweetener for weight management and compositions sweetened therewith |
US8962058B2 (en) * | 2005-11-23 | 2015-02-24 | The Coca-Cola Company | High-potency sweetener composition with antioxidant and compositions sweetened therewith |
US8524304B2 (en) | 2005-11-23 | 2013-09-03 | The Coca-Cola Company | High-potency sweetener composition with probiotics/prebiotics and compositions sweetened therewith |
US8367137B2 (en) | 2005-11-23 | 2013-02-05 | The Coca-Cola Company | High-potency sweetener composition with fatty acid and compositions sweetened therewith |
US8435588B2 (en) | 2005-11-23 | 2013-05-07 | The Coca-Cola Company | High-potency sweetener composition with an anti-inflammatory agent and compositions sweetened therewith |
US8435587B2 (en) | 2005-11-23 | 2013-05-07 | The Coca-Cola Company | High-potency sweetener composition with long-chain primary aliphatic saturated alcohol and compositions sweetened therewith |
US8367138B2 (en) | 2005-11-23 | 2013-02-05 | The Coca-Cola Company | Dairy composition with high-potency sweetener |
US9101160B2 (en) * | 2005-11-23 | 2015-08-11 | The Coca-Cola Company | Condiments with high-potency sweetener |
DE602007011796D1 (en) | 2006-10-24 | 2011-02-17 | Givaudan Sa | CONSUMPTION PRODUCTS |
US9101161B2 (en) | 2006-11-02 | 2015-08-11 | The Coca-Cola Company | High-potency sweetener composition with phytoestrogen and compositions sweetened therewith |
US9877500B2 (en) * | 2007-03-14 | 2018-01-30 | Concentrate Manufacturing Company Of Ireland | Natural beverage products |
US20130071521A1 (en) * | 2007-03-14 | 2013-03-21 | Pepsico, Inc. | Rebaudioside d sweeteners and food products sweetened with rebaudioside d |
US8277862B2 (en) † | 2007-03-14 | 2012-10-02 | Concentrate Manufacturing Company Of Ireland | Beverage products having steviol glycosides and at least one acid |
JP5555147B2 (en) * | 2010-12-06 | 2014-07-23 | サンスター株式会社 | A composition containing ascorbic acid and its analogs stably. |
-
1996
- 1996-11-14 JP JP30260196A patent/JP4726269B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH09194370A (en) | 1997-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4726269B2 (en) | Oral solution | |
KR101531202B1 (en) | Method of improving sweetness qualities of stevia extract | |
EP2058297B1 (en) | Use of alkamides for masking an unpleasant flavor | |
KR101411035B1 (en) | Taste-improving agent and food or drink containing the same | |
JP3843009B2 (en) | Oral material with improved taste, method for improving taste of oral material and method for using enzyme-treated ginkgo biloba extract | |
US8609069B2 (en) | Rebaudioside C and its stereoisomers as natural product sweetness enhancers | |
CN105307502A (en) | Rebaudioside e and food products sweetened with rebaudioside e | |
JP2003235512A (en) | Amino acid-containing composition improved in taste | |
US20110224311A1 (en) | Natural Product Sweetness Enhancers | |
JP2013192513A (en) | Black ginger extract composition, black ginger extract-containing food and drink, and method for improving taste of black ginger extract | |
JP4502549B2 (en) | Water-dispersible or water-soluble ginkgo biloba extract composition | |
JP5162812B2 (en) | Zinc-containing composition for oral administration | |
JP2001258502A (en) | Sweetener composition, method for imparting sweetness and its use | |
JP4037035B2 (en) | Flavor improver | |
JP2001321114A (en) | Sweetness composition and food and drink containing the same | |
JP2004033226A (en) | Sweetener composition, method for imparting sweetness and application thereof | |
JP4278896B2 (en) | Hihatsu fruit extract composition, food and drink containing Hihatsu fruit extract, and method for improving taste of Hihatsu fruit extract | |
JP2001086941A (en) | Excellently gustatory extract composition derived from flower part of basswood | |
JP2005073588A (en) | Saponin containing oral product and method for reducing unpleasant taste of saponin | |
JP2005110548A (en) | Food composition containing methylsulfonylmethane | |
JP6021842B2 (en) | Black ginger extract composition, food and drink containing black ginger extract, and method for improving taste of black ginger extract | |
JP2000239154A (en) | Internal medicine composition containing iron compound | |
JPH1059843A (en) | Oral liquid medicine | |
JP2019208503A (en) | Acid taste enhancing agent, and acid ingredient-containing composition containing the same | |
EP2880992A2 (en) | Rebaudioside C and its stereoisomers as natural product sweetness enhancers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070828 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071026 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20071026 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080115 |
|
RD07 | Notification of extinguishment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7427 Effective date: 20090605 |
|
RD07 | Notification of extinguishment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7427 Effective date: 20090624 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110315 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110412 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140422 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140422 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |